Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other Non-Current Assets (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Non-Current Assets for 16 consecutive years, with $1000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets fell 99.03% to $1000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1000.0, a 99.03% decrease, with the full-year FY2024 number at $103000.0, down 26.95% from a year prior.
  • Other Non-Current Assets was $1000.0 for Q3 2025 at Xtant Medical Holdings, down from $15000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $322000.0 in Q1 2021 to a low of $1000.0 in Q1 2025.
  • A 5-year average of $170157.9 and a median of $185000.0 in 2023 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: fell 8.68% in 2022, then tumbled 99.24% in 2025.
  • Xtant Medical Holdings' Other Non-Current Assets stood at $287000.0 in 2021, then plummeted by 31.36% to $197000.0 in 2022, then dropped by 28.43% to $141000.0 in 2023, then decreased by 26.95% to $103000.0 in 2024, then tumbled by 99.03% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Other Non-Current Assets are $1000.0 (Q3 2025), $15000.0 (Q2 2025), and $1000.0 (Q1 2025).